Literature DB >> 19711439

Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?

Arnold C Paulino1, Alberto Pappo.   

Abstract

Alveolar rhabdomyosarcoma (RMS) of the extremity is not infrequently associated with regional node metastasis. Knowledge of lymphatic drainage of extremity RMSs is important to determine radiotherapy fields. In this report we describe two patients with alveolar RMS of the lower extremity with inguinal metastasis at presentation. Both the distal lower extremity and inguinal region received local therapy consisting of surgery and postoperative radiotherapy. Both patients later developed in-transit lymphatic metastasis outside of the irradiated field. The in-transit lymphatics can be a site of failure in children with alveolar RMS of the extremity and nodal involvement. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19711439     DOI: 10.1002/pbc.22252

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  4 in total

1.  Regional nodal involvement and patterns of spread along in-transit pathways in children with rhabdomyosarcoma of the extremity: a report from the Children's Oncology Group.

Authors:  Trang H La; Suzanne L Wolden; David A Rodeberg; Douglas S Hawkins; Kenneth L Brown; James R Anderson; Sarah S Donaldson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-11       Impact factor: 7.038

2.  Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups.

Authors:  Odile Oberlin; Annie Rey; Kenneth L B Brown; Gianni Bisogno; Ewa Koscielniak; Michael C G Stevens; Douglas S Hawkins; William H Meyer; Trang H La; Modesto Carli; James R Anderson
Journal:  Pediatr Blood Cancer       Date:  2015-08-10       Impact factor: 3.167

3.  High incidence of regional and in-transit lymph node metastasis in patients with alveolar rhabdomyosarcoma.

Authors:  Yoshihiro Nishida; Satoshi Tsukushi; Hiroshi Urakawa; Hideshi Sugiura; Hiroatsu Nakashima; Yoshihisa Yamada; Naoki Ishiguro
Journal:  Int J Clin Oncol       Date:  2013-06-04       Impact factor: 3.402

Review 4.  Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges.

Authors:  Lingling Zhu; Xianzhe Yu; Li Wang; Jiewei Liu; Zihan Qu; Honge Zhang; Lu Li; Jiang Chen; Qinghua Zhou
Journal:  Oncogenesis       Date:  2021-07-10       Impact factor: 7.485

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.